AMR and Sustainable Development Goals: at a crossroads.

Alternatives to Antibiotics Antimicrobial Resistance (AMR) Antimicrobial Stewardship One Health Socio-Economic Impacts Sustainable Development Goals (SDGs)

Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 20 01 2024
accepted: 24 04 2024
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

Antimicrobial resistance (AMR) poses a significant global health threat, primarily stemming from its misuse and overuse in both veterinary and public healthcare systems. The consequences of AMR are severe, leading to more severe infections, increased health protection costs, prolonged hospital stays, unresponsive treatments, and elevated fatality rates. The impact of AMR is direct and far-reaching, particularly affecting the Sustainable Development Goals (SDGs), underscoring the urgency for concerted global actions to achieve these objectives. Disproportionately affecting underprivileged populations, AMR compounds their vulnerabilities, pushing them further into poverty. Moreover, AMR has ramifications for food production, jeopardizing sustainable agriculture and diminishing the livelihoods of farmers. The emergence of antibiotic-resistant bacteria in underprivileged areas heightens the risk of complications and mortality. Climate change further contributes to AMR, as evidenced by increased instances of foodborne salmonellosis and the development of antibiotic resistance, resulting in substantial healthcare costs. Effectively addressing AMR demands collaboration among governments, entrepreneurs, and the public sector to establish institutions and policies across all regulatory levels. Expanding SDG 17, which focuses on partnerships for sustainable development, would facilitate global antimicrobial stewardship initiatives, technology transfer, surveillance systems, and investment in vaccine and drug research. The World Bank's SDG database, tracking progress towards sustainable development, reveals a concerning picture with only a 15% success rate till 2023 and 48% showing deviation, underscoring a global gap exacerbated by the COVID-19 pandemic. Tackling AMR's global impact necessitates international cooperation, robust monitoring, and evaluation methods. The five priorities outlined guide SDG implementation, while impoverished countries must address specific challenges in their implementation efforts. Addressing AMR and its impact on the SDGs is a multifaceted challenge that demands comprehensive and collaborative solutions on a global scale.

Identifiants

pubmed: 39415207
doi: 10.1186/s12992-024-01046-8
pii: 10.1186/s12992-024-01046-8
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

73

Informations de copyright

© 2024. The Author(s).

Références

Afionis S, Sakai M, Scott K, Barrett J, Gouldson A. Consumption-based carbon accounting: does it have a future? Wiley Interdisciplin Rev. 2017;8(1): e438.
Ahmad M, Khan AU. Global economic impact of antibiotic resistance: A review. J Global Antimicrobial Resist. 2019;19:313–6.
doi: 10.1016/j.jgar.2019.05.024
Arsene MMJ, Jorelle AB, Sarra S, Viktorovna PI, Davares AK, Ingrid NK, Steve AA, Andreevna SL, Vyacheslavovna YN, Carime BZ. A short review on the potential alternatives to antibiotics in the era of antibiotic resistance. J Appl Pharm Sci. 2022;12(1):29–40.
Ashiru-Oredope D, Utilization S. H. o. b. o. t. E. S. P. f. A., Group, R. O., Kessel A, Hopkins S., Ashiru-Oredope D., Brown B, Brown N, Carter S, Charlett A, & Cichowka A. Antimicrobial stewardship: English surveillance programme for antimicrobial utilization and resistance (ESPAUR). J AntimicrobChemother. 2013;68(11):2421-2423
Ateshim Y, Bereket B, Major F, Emun Y, Woldai B, Pasha I, Habte E, Russom M. Prevalence of self-medication with antibiotics and associated factors in the community of Asmara, Eritrea: a descriptive cross sectional survey. BMC Public Health. 2019;19(1):1–7.
doi: 10.1186/s12889-019-7020-x
Atlas R M. One Health: its origins and future. One Health: The Human-Animal-Environment Interfaces in Emerging Infectious Diseases: The Concept and Examples of a One Health Approach. 2012:1–13.
Bakshi, S., & Kumar, I. India and Sustainable Development Goals (SDGs). Policy brief, November 2013. Energy and Resources Institute, New Delhi. 2013.
Bangert M, Molyneux DH, Lindsay SW, Fitzpatrick C, Engels D. The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals. Infect Dis Poverty. 2017;6(1):1–20.
doi: 10.1186/s40249-017-0288-0
Bank, W. Drug-resistant infections: a threat to our economic future. World Bank. 2017.
Barbier EB, Burgess JC. Sustainable development goal indicators: Analyzing trade-offs and complementarities. World Dev. 2019;122:295–305.
doi: 10.1016/j.worlddev.2019.05.026
Baris, E., Thiebaud, A., & Evans, T. Containing antimicrobial resistance is a smart investment in global public health and wealth. AMR Control. 2017.
Beisheim M, Løkken H, Aus Dem Moore N, Pintér L, & Rickels W. Measuring sustainable development: How can science contribute to realizing the SDGs. SWP Berlin: Berlin, Germany. 2015;8:1-32
Blanchfield L, & Lawson ML. The millennium development goals: the September 2010 UN high-level meeting. Congressional Research Service. 2010.
Blaskovich MA. The fight against antimicrobial resistance is confounded by a global increase in antibiotic usage. ACS Infect Dis. 2018;4(6):868–70.
pubmed: 29757608 doi: 10.1021/acsinfecdis.8b00109
Bloom G, Merrett GB, Wilkinson A, Lin V, Paulin S. Antimicrobial resistance and universal health coverage. BMJ Glob Health. 2017;2(4): e000518.
pubmed: 29225955 pmcid: 5717966 doi: 10.1136/bmjgh-2017-000518
Brels, S. The UN-iversalization of Animal Welfare Law. 2022.
Briliyanti A, Wilson Rojewski J, Luchini-Colbry K, & Colbry D. CyberAmbassadors: Results from pilot testing a new professional skills curriculum. In Practice and Experience in Advanced Research Computing (pp. 379–385). 2020 .
Buchy P, Ascioglu S, Buisson Y, Datta S, Nissen M, Tambyah PA, Vong S. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020;90:188–96.
pubmed: 31622674 doi: 10.1016/j.ijid.2019.10.005
Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini G. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413–31.
pubmed: 22507109 doi: 10.1111/j.1469-0691.2012.03821.x
CDC. Antibiotic resistance threats in the United States, 2019. US Department of Health and Human Services, Centres for Disease Control and …. 2019.
Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage WP. Antibiotics in agriculture and the risk to human health: how worried should we be? Evol Appl. 2015;8(3):240–7.
pubmed: 25861382 doi: 10.1111/eva.12185
Chaw P, Höpner J, Mikolajczyk R. The knowledge, attitude and practice of health practitioners towards antibiotic prescribing and resistance in developing countries—A systematic review. J Clin Pharm Ther. 2018;43(5):606–13.
pubmed: 29959783 doi: 10.1111/jcpt.12730
Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Global Infect Dis. 2019;11(1):36.
doi: 10.4103/jgid.jgid_110_18
Chowdhury AS, Lofgren ET, Moehring RW, Broschat SL. Identifying predictors of antimicrobial exposure in hospitalized patients using a machine learning approach. J Appl Microbiol. 2020;128(3):688–96.
pubmed: 31651068 doi: 10.1111/jam.14499
Cipullo N. Biodiversity Indicators: the accounting point of view. Proc Econ Finance. 2016;39:539–44.
doi: 10.1016/S2212-5671(16)30297-0
Cook R, Karesh W, & Osofsky S. One World, One Health: Building interdisciplinary bridges to health in a globalized world. Wildlife Conservation Society, Bronx, New York, USA. 2004.  http://www.oneworldonehealth.org/sept2004/owohsept04.html . Accessed 18 Apr 2016. 
Dadgostar P. Antimicrobial resistance: implications and costs. Infection and drug resistance. 2019: 3903–3910.
Davies SC, Walker D, Fowler T. Infections and the rise of antimicrobial resistance. Ann Rep Chief Med Officer. 2013;2:73–86.
Dwidar M, Monnappa AK, Mitchell RJ. The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. BMB Rep. 2012;45(2):71–8.
pubmed: 22360883 doi: 10.5483/BMBRep.2012.45.2.71
El Lawindi MI, Galal YS, Khairy WA. Health research and millennium development goals: Identifying the gap from public health perspective. Global J Health Sci. 2016;8(5):1.
doi: 10.5539/gjhs.v8n5p1
Epizooties OId. OIE Fifth Annual Report Factsheet: Antimicrobial agents intended for use in animals. 2021. https://www.woah.org/app/uploads/2021/05/en-5th-annual-report-factsheet-final-ld-compresse.pdf .
FAO. The FAO action plan on antimicrobial resistance 2021–2025. FAO. 2021.
Fehling M, Nelson BD, Venkatapuram S. Limitations of the millennium development goals: a literature review. Glob Public Health. 2013;8(10):1109–22.
pubmed: 24266508 pmcid: 3877943 doi: 10.1080/17441692.2013.845676
Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS ONE. 2017;12(12): e0189621.
pubmed: 29267306 pmcid: 5739407 doi: 10.1371/journal.pone.0189621
François B, Jafri HS, Bonten M. Alternatives to antibiotics. Intens Care Med. 2016;42:2034–6.
doi: 10.1007/s00134-016-4339-y
Gaggìa F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol. 2010;141:S15–28.
pubmed: 20382438 doi: 10.1016/j.ijfoodmicro.2010.02.031
Gajdács M, Urbán E, Stájer A, Baráth Z. Antimicrobial resistance in the context of the sustainable development goals: A brief review. Eur J Invest Health Psychol Educ. 2021;11(1):71–82.
Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. Early implementation. (2020). https://www.who.int/publications/i/item/9789240005587 .
Goff DA, Kullar R, Goldstein EJ, Gilchrist M, Nathwani D, Cheng AC, Cairns KA, Escandón-Vargas K, Villegas MV, Brink A. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017;17(2):e56–63.
pubmed: 27866945 doi: 10.1016/S1473-3099(16)30386-3
Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7(7): e1002158.
pubmed: 21811410 pmcid: 3141051 doi: 10.1371/journal.ppat.1002158
Huang Q, Horn MA, Ruan S. Modeling the effect of antibiotic exposure on the transmission of methicillin-resistant Staphylococcus aureus in hospitals with environmental contamination. Math Biosci Eng. 2019;16(5):3641–73.
pubmed: 31499630 doi: 10.3934/mbe.2019181
Hughes D, Karlén A. Discovery and preclinical development of new antibiotics. Upsala J Med Sci. 2014;119(2):162–9.
pubmed: 24646082 pmcid: 4034554 doi: 10.3109/03009734.2014.896437
Irfan M, Almotiri A, AlZeyadi ZA. Antimicrobial resistance and its drivers—A review. Antibiotics. 2022;11(10):1362.
pubmed: 36290020 pmcid: 9598832 doi: 10.3390/antibiotics11101362
Jasovský D, Littmann J, Zorzet A, Cars O. Antimicrobial resistance—a threat to the world’s sustainable development. Upsala J Med Sci. 2016;121(3):159–64.
pubmed: 27416324 pmcid: 4967260 doi: 10.1080/03009734.2016.1195900
Jonas OB, Irwin A, Berthe FCJ, Le Gall FG, & Marquez PV.Drug-resistant infections : a threat to our economic future (Vol. 2) : final report T. W. Bank. 2017.
JT B. Health in 2015: from MDGs, millennium development goals to SDGs, sustainable development goals. 2015.
Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, Dingle TC, Chen JZ, Tyrrell GJ, Ronksley PE. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021). Antimicrob Resist Infect Control. 2022;11(1):45.
pubmed: 35255988 pmcid: 8899460 doi: 10.1186/s13756-022-01085-z
Kearns J. The role of chemical exposures in reducing the effectiveness of water–sanitation–hygiene interventions in Bangladesh, Kenya, and Zimbabwe. Wiley Interdiscip Rev Water. 2020;7(5): e1478.
doi: 10.1002/wat2.1478
Khor WP, Olaoye O, D’Arcy N, Krockow EM, Elshenawy RA, Rutter V, Ashiru-Oredope D. The need for ongoing antimicrobial stewardship during the COVID-19 pandemic and actionable recommendations. Antibiotics. 2020;9(12):904.
pubmed: 33327430 pmcid: 7764884 doi: 10.3390/antibiotics9120904
Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–70.
pubmed: 29581252 pmcid: 5899442 doi: 10.1073/pnas.1717295115
Kumar S, Kumar N, Vivekadhish S. Millennium development goals (MDGS) to sustainable development goals (SDGS): Addressing unfinished agenda and strengthening sustainable development and partnership. Indian J Commun Med. 2016;41(1):1.
doi: 10.4103/0970-0218.170955
Leal Filho W, Tripathi SK, Andrade Guerra J, Giné-Garriga R, Orlovic Lovren V, Willats J. Using the sustainable development goals towards a better understanding of sustainability challenges. Int J Sust Dev World. 2019;26(2):179–90.
doi: 10.1080/13504509.2018.1505674
Lekagul A, Tangcharoensathien V, Yeung S. Patterns of antibiotic use in global pig production: a systematic review. Vet Anim Sci. 2019;7: 100058.
pubmed: 32734079 pmcid: 7386699 doi: 10.1016/j.vas.2019.100058
Lomazzi M, Theisling M, Tapia L, Borisch B, Laaser U. MDGs–a public health professional’s perspective from 71 countries. J Public Health Policy. 2013;34:e1–22.
pubmed: 23407414 doi: 10.1057/jphp.2012.69
Lu, Y., Nakicenovic, N., Visbeck, M., & Stevance, A.-S. Five priorities for the UN sustainable development goals. In (Vol. 520, pp. 432–433): Nature Publishing group Macmillan Building, 4 Crinan St, london N1 9XW, England. 2015.
MacFadden DR, McGough SF, Fisman D, Santillana M, Brownstein JS. Antibiotic resistance increases with local temperature. Nat Clim Chang. 2018;8(6):510–4.
pubmed: 30369964 pmcid: 6201249 doi: 10.1038/s41558-018-0161-6
Mackenzie JS, & Jeggo M. The One Health approach—Why is it so important? In (Vol. 4, pp. 88): MDPI. 2019.
Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, & Gittens-St Hilaire, M. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020:4713–4738.
Mantegazza L, De Pascali AM, Munoz O, Manes C, Scagliarini A, Capua I. Circular Health: exploiting the SDG roadmap to fight AMR. Front Cell Infect Microbiol. 2023;13:1185673.
pubmed: 37424780 pmcid: 10324666 doi: 10.3389/fcimb.2023.1185673
Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011;24(4):718–33.
pubmed: 21976606 pmcid: 3194830 doi: 10.1128/CMR.00002-11
McGowan Jr J, & Gerding D. Does antibiotic restriction prevent resistance? New horizons (Baltimore, Md.). 1996; 4(3):370–376.
Meyfroidt P, Lambin EF, Erb K-H, Hertel TW. Globalization of land use: distant drivers of land change and geographic displacement of land use. Curr Opin Environ Sustain. 2013;5(5):438–44.
doi: 10.1016/j.cosust.2013.04.003
Morton S, Pencheon D, Squires N. Sustainable Development Goals (SDGs), and their implementation: A national global framework for health, development and equity needs a systems approach at every level. Br Med Bull. 2017;124(1):81–90.
pubmed: 29069332
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, Han C, Bisignano C, Rao P, Wool E. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.
doi: 10.1016/S0140-6736(21)02724-0
New resistance-busting antibiotic combination could extend the use of ‘last-resort’ antibiotics. 2021. https://www.ox.ac.uk/news/2021-12-14-new-resistance-busting-antibiotic-combination-could-extend-use-last-resort#:~:text=last%2Dresort'%20antibiotics-,New%20resistance%2Dbusting%20antibiotic%20combination%20could%20extend%20the,of%20'last%2Dresort'%20antibiotics&text=Scientists%20have%20discovered%20a%20new,pneumonia%2C%20and%20urinary%20tract%20infections .
Nilsson M, Griggs D, Visbeck M. Policy: map the interactions between Sustainable Development Goals. Nature. 2016;534(7607):320–2.
pubmed: 27306173 doi: 10.1038/534320a
O'Neill, J. Tackling drug-resistant infections globally: final report and recommendations. 2016.
OIE. UN Environment Programme joins "Quadripartite" alliance for One Health. 2022. https://www.woah.org/en/un-environment-programme-joins-alliance-to-implement-one-health-approach/ .
Parisien A, Allain B, Zhang J, Mandeville R, Lan C. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol. 2008;104(1):1–13.
pubmed: 18171378
Parliament E, Council. Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition. Off J Eur Union. 2003;268:29–43.
PaulSatyaseela M. Anti-Microbial-Resistance: Impact on One Health, Sustainable Development Goals, Microbiome & Policy. Health Policy Res. 2022;1(1). 
Payumo J, Alocilja E, Boodoo C, Luchini-Colbry K, Ruegg P, McLamore E, Vanegas D, Briceno RK, Castaneda-Sabogal A, Watanabe K. Next generation of amr network. Encyclopedia. 2021;1(3):871–92.
doi: 10.3390/encyclopedia1030067
Raviglione M, Maher D. Ending infectious diseases in the era of the Sustainable Development Goals. Porto Biomed J. 2017;2(5):140–2.
pubmed: 32258607 pmcid: 6806806 doi: 10.1016/j.pbj.2017.08.001
Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–68.
pubmed: 32358954
Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. Triazole resistance in Aspergillus spp: a worldwide problem? JFungi. 2016;2(3):21.
Rodríguez-González A, Zanin M, Menasalvas-Ruiz E. Public health and epidemiology informatics: can artificial intelligence help future global challenges? An overview of antimicrobial resistance and impact of climate change in disease epidemiology. Yearb Med Inform. 2019;28(01):224–31.
pubmed: 31419836 pmcid: 6697502 doi: 10.1055/s-0039-1677910
Roe D, Dickman A, Kock R, Milner-Gulland E, Rihoy E. Beyond banning wildlife trade: COVID-19, conservation and development. World Dev. 2020;136: 105121.
pubmed: 32834392 pmcid: 7388857 doi: 10.1016/j.worlddev.2020.105121
Rosenblatt-Farrell N. The landscape of antibiotic resistance. In: National Institute of Environmental Health Sciences. 2009.
Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G. Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Eurosurveillance. 2014;19(14):20768.
pubmed: 24739981 doi: 10.2807/1560-7917.ES2014.19.14.20768
Sachs JD, Kroll C, Lafortune G, Fuller G, Woelm F. Sustainable development report 2022. Cambridge University Press; 2022.
doi: 10.1017/9781009210058
San Millan A. Evolution of plasmid-mediated antibiotic resistance in the clinical context. Trends Microbiol. 2018;26(12):978–85.
pubmed: 30049587 doi: 10.1016/j.tim.2018.06.007
Sarvajayakesavalu S. Addressing challenges of developing countries in implementing five priorities for sustainable development goals. Ecosystem Health Sustain. 2015;1(7):1–4.
doi: 10.1890/EHS15-0028.1
Sarwar MB. National MDG implementation. In: London: Overseas Development Institute. 2015.
Savoia D. Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiol. 2012;7(8):979–90.
pubmed: 22913356 doi: 10.2217/fmb.12.68
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, Jones JL, Griffin PM. Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis. 2011;17(1):7.
pubmed: 21192848 pmcid: 3375761 doi: 10.3201/eid1701.P11101
Schapper A, Bliss C. Transforming our world? Strengthening animal rights and animal welfare at the United Nations. Int Relations. 2023;37(3):514–37.
doi: 10.1177/00471178231193299
Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol. 2012;33(4):338–45.
pubmed: 22418628 doi: 10.1086/664909
Sudsawasd S, Charoensedtasin T, Pholphirul P. Does international trade enable a country to achieve Sustainable Development Goals? Empirical findings from two research methodologies. Int J Sust Dev World. 2020;27(5):405–18.
doi: 10.1080/13504509.2019.1709913
Sun D, Jeannot K, Xiao Y, & Knapp CW. Horizontal gene transfer mediated bacterial antibiotic resistance. In (Vol. 10, pp. 1933): Frontiers Media SA. 2019.
Tang KWK, Millar BC, Moore JE. Antimicrobial Resistance (AMR). Br J Biomed Sci. 2023;80:11387.
pubmed: 37448857 pmcid: 10336207 doi: 10.3389/bjbs.2023.11387
Tavsanli H, Aydin M, Ede Z, Cibik R. Influence of ultrasound application on the microbiota of raw goat milk and some food pathogens including Brucella melitensis. Food Sci Technol Int. 2022;28(7):634–40.
pubmed: 34612743 doi: 10.1177/10820132211049601
Taylor J, Hafner M, Yerushalmi E, Smith R, Bellasio J, Vardavas R, Bienkowska-Gibbs T, & Rubin J. Estimating the economic costs of antimicrobial resistance. Model and Results (RAND Corporation, Cambridge, UK). 2014.
Toner E, Adalja A, Gronvall GK, Cicero A, Inglesby TV. Antimicrobial resistance is a global health emergency. Health security. 2015;13(3):153–5.
pubmed: 26042858 pmcid: 4486712 doi: 10.1089/hs.2014.0088
UN. The Sustainable Development Goals Report 2020. 2020.  https://unstats.un.org/sdgs/report/2020/The-Sustainable-Development-Goals-Report-2020.pdf .
UN. Sustainable development goals:Progress Chart 2023. 2023.  https://unstats.un.org/sdgs/report/2023/progress-chart/ .
UNCTAD. Trade and development report, 2015. U. N. Publication. 2015.  https://unctad.org/system/files/official-document/tdr2015_en.pdf .
UNCTAD. Trading into sustainable development: trade, market access, and the sustainable development goals. Developing countries in international trade studies. https://unctad.org/publication/trading-sustainable-development-trade-market-access-and-sustainable-development-goals . 2016.
Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, Teillant A, Laxminarayan R. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci. 2015;112(18):5649–54.
pubmed: 25792457 pmcid: 4426470 doi: 10.1073/pnas.1503141112
Van Panhuis WG, Grefenstette J, Jung SY, Chok NS, Cross A, Eng H, Lee BY, Zadorozhny V, Brown S, Cummings D. Contagious diseases in the United States from 1888 to the present. N Engl J Med. 2013;369(22):2152.
pubmed: 24283231 pmcid: 4175560 doi: 10.1056/NEJMms1215400
Verniers E, Brels S. UNCAHP, one health, and the sustainable development goals. J Int Wildlife Law Policy. 2021;24(1):38–56.
doi: 10.1080/13880292.2021.1923731
WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017.  https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed .
WHO. WHO global principles for the containment of antimicrobial resistance in animals intended for food: report of a WHO consultation with the participation of the Food and Agriculture Organization of the United Nations and the Office International des Epizooties, Geneva, Switzerland. 2000.
WHO. Global action plan on antimicrobial resistance. T. W. e. Organization. 2016.  https://iris.who.int/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1 .
WHO. 2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, World Health Organization. 2019a.
WHO. Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit. 2019b.
WHO. Turning plans into action for antimicrobial resistance (AMR): working paper 2.0: implementation and coordination. 2019c.
WTO. World Trade Report 2012. Trade and public policies: A closer look at non-tariff measures in the 21st century. T. W. T. Organization. 2012.  https://www.wto.org/english/res_e/booksp_e/anrep_e/world_trade_report12_e.pdf .
Xu Z, Li Y, Chau SN, Dietz T, Li C, Wan L, Zhang J, Zhang L, Li Y, Chung MG. Impacts of international trade on global sustainable development. Nat Sustain. 2020;3(11):964–71.
doi: 10.1038/s41893-020-0572-z
Zhao W, Yin C, Hua T, Meadows ME, Li Y, Liu Y, Cherubini F, Pereira P, Fu B. Achieving the sustainable development goals in the post-pandemic era. Human Soc Sci Commun. 2022;9(1):1–7.

Auteurs

Bilal Aslam (B)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan. drbilalaslam@gcuf.edu.pk.

Rubab Asghar (R)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Saima Muzammil (S)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Muhammad Shafique (M)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Abu Baker Siddique (AB)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Mohsin Khurshid (M)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Muhammad Ijaz (M)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Muhammad Hidayat Rasool (MH)

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Tamoor Hamid Chaudhry (TH)

National Institute of Health, Islamabad, Pakistan.

Afreenish Aamir (A)

National Institute of Health, Islamabad, Pakistan.

Zulqarnain Baloch (Z)

Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, People's Republic of China. znbaloch@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH